Company family · HQ CH
Roche: medicine shortages
ROG · SIX Swiss
As of 2 Nov 2026, 29 Roche products have a reported shortage across 7 countries, covering 14 medicines.
Products short29rank #71 of 464
Medicines14active ingredients
Countries7/16
New in 90 days3+1 vs market pace
Typical duration14 monthsmedian so far
Manufacturing56%demand-driven 11%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Long-run trend in Canada
Canada dashboardCanada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Erythropoietin | 7 | 7 Jul 2025 | Manufacturing problem | 6/16 | |
| Oseltamivir | 3 | 7 Jan 2024 | Increased demand | 4/16 | |
| Pirfenidone | 3 | not given | Not stated | 6/16 | |
| Alteplase | 2 | 21 May 2026 | Not stated | 2/16 | |
| Baloxavir Marboxil | 1 | 22 Apr 2026 | Other | 1/16 | |
| Cilazapril | 1 | 26 Nov 2018 | Other | 1/16 | |
| Enfuvirtide | 1 | not given | Not stated | 1/16 | |
| Erlotinib | 1 | 14 Feb 2022 | Other | 5/16 | |
| Mycophenolic Acid | 1 | 22 Mar 2026 | Not stated | 6/16 | |
| Pertuzumab and Trastuzumab | 1 | not given | Not stated | 1/16 | |
| Pralsetinib | 1 | not given | Not stated | 1/16 | |
| Risdiplam | 1 | 23 Sep 2026 | Manufacturing problem | 1/16 | |
| Saquinavir | 1 | not given | Not stated | 1/16 | |
| Vemurafenib | 1 | 30 Oct 2026 | Other | 2/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.